Penis Kanserinde Lazer Ablasyon
Özet
Penis kanseri, nadir görülen ve genellikle prepusyal doku ile glans penisten kaynaklanan skuamöz hücreli karsinom tipinde bir malignitedir. Hastalığın gelişiminde fimozis, kronik enflamasyon, HPV enfeksiyonu ve sigara kullanımı önemli risk faktörleri arasında yer almaktadır. Erken evrede tanı konulduğunda %80’in üzerinde kür şansı sunan bu hastalıkta tedavi yaklaşımı, onkolojik güvenliği tehlikeye atmadan organın maksimum düzeyde korunmasını hedefler. Bu doğrultuda, özellikle Tis, Ta ve T1a gibi erken evre tümörlerin tedavisinde Nd:YAG, CO2 ve Tm:YAG lazer ablasyon yöntemleri sıkça tercih edilmektedir. Karbondioksit (CO2) lazeri epidermal buharlaşma yoluyla yüzeysel ablasyon sağlarken, Nd:YAG lazeri daha derin doku penetrasyonu ile koagülasyon nekrozu oluşturur; Tm:YAG lazeri ise düşük penetrasyon derinliğiyle minimal kanama riski sunar. Klinik çalışmalar, bu lazer modalitelerinin kozmetik ve seksüel fonksiyonların korunmasında mükemmel başarı sağladığını ve kansere özgü sağkalım oranlarının yüksek olduğunu göstermektedir. Bununla birlikte, organ koruyucu bu yaklaşımlarda lokal nüks oranlarının yüksek seyretmesi nedeniyle, hastaların tedavi sonrasında yakın klinik takibe alınması ve düzenli olarak kendi kendilerini muayene etmeleri hayati önem taşımaktadır.
Penile cancer is a rare malignancy predominantly characterized by squamous cell carcinoma, originating from the preputial tissue and glans penis. Key risk factors driving its pathogenesis include phimosis, chronic penial inflammation, high-risk HPV infection, and cigarette smoking. When diagnosed in its early stages, the disease offers a high cure rate exceeding 80%, with contemporary management strategies shifting toward organ-preserving modalities to maintain functional and cosmetic integrity without compromising oncological control. Laser ablation using Nd:YAG, CO2, and Tm:YAG sources is highly recommended and widely utilized for treating early-stage tumors, specifically Tis, Ta, and T1a categories. The CO2 laser induces vaporization of epidermal cells with shallow tissue penetration, whereas the Nd:YAG laser achieves deeper thermal penetration for coagulation necrosis, and the Tm:YAG laser features precise superficial ablation with a significantly reduced risk of bleeding. Clinical trials indicate that while laser treatments deliver superior functional outcomes and excellent cancer-specific survival rates, they are inherently associated with higher local recurrence rates. Consequently, stringent post-treatment clinical surveillance combined with regular patient self-examination is universally deemed imperative to promptly detect potential recurrences.
Referanslar
Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control. 2009;20(4):449-57.
Chaux A, Netto GJ, Rodríguez IM, Barreto JE, Oertell J, Ocampos S, Boggino H, Codas R, Xavier Bosch F, de Sanjose S, Muñoz N, Hildesheim A, Cubilla AL. Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol. 2013;31(4):861-7.
Maden C, Sherman KJ, Beckmann AM, Hislop TG, Teh CZ, Ashley RL, Daling JR. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst. 1993;85(1):19-24.
Tsen HF, Morgenstern H, Mack T, Peters RK. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control. 2001;12(3):267-77.
Afonso LA, Cordeiro TI, Carestiato FN, Ornellas AA, Alves G, Cavalcanti SM. High Risk Human Papillomavirus Infection of the Foreskin in Asymptomatic Men and Patients with Phimosis. J Urol. 2016;195(6):1784-9.
Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26 Suppl 3:22-31.
Stern RS; PUVA Follow-Up Study. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol. 2012;66(4):553-62.
Stankiewicz E, Kudahetti SC, Prowse DM, Ktori E, Cuzick J, Ambroisine L, Zhang X, Watkin N, Corbishley C, Berney DM. HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis. Mod Pathol. 2009;22(9):1160-8.
Daling JR, Sherman KJ, Hislop TG, Maden C, Mandelson MT, Beckmann AM, Weiss NS. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol. 1992 Jan 15;135(2):180-9.
Koifman L, Vides AJ, Koifman N, Carvalho JP, Ornellas AA. Epidemiological aspects of penile cancer in Rio de Janeiro: evaluation of 230 cases. Int Braz J Urol. 2011;37(2):231-40.
Thuret R, Sun M, Budaus L, Abdollah F, Liberman D, Shariat SF, Iborra F, Guiter J, Patard JJ, Perrotte P, Karakiewicz PI. A population-based analysis of the effect of marital status on overall and cancer-specific mortality in patients with squamous cell carcinoma of the penis. Cancer Causes Control. 2013;24(1):71-9.
McIntyre M, Weiss A, Wahlquist A, Keane T, Clarke H, Savage S. Penile cancer: an analysis of socioeconomic factors at a southeastern tertiary referral center. Can J Urol. 2011;18(1):5524-8.
Benard VB, Johnson CJ, Thompson TD, Roland KB, Lai SM, Cokkinides V, Tangka F, Hawkins NA, Lawson H, Weir HK. Examining the association between socioeconomic status and potential human papillomavirus-associated cancers. Cancer. 2008;113(10 Suppl):2910-8.
Dillner J, von Krogh G, Horenblas S, Meijer CJ. Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl. 2000;(205):189-93.
Ulff-Møller CJ, Simonsen J, Frisch M. Marriage, cohabitation and incidence trends of invasive penile squamous cell carcinoma in Denmark 1978-2010. Int J Cancer. 2013 Sep 1;133(5):1173-9.
Van Howe RS, Hodges FM. The carcinogenicity of smegma: debunking a myth. J Eur Acad Dermatol Venereol. 2006;20(9):1046-54.
Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK, Krieger JN. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005;116(4):606-16.
Velazquez EF, Cubilla AL. Lichen sclerosus in 68 patients with squamous cell carcinoma of the penis: frequent atypias and correlation with special carcinoma variants suggests a precancerous role. Am J Surg Pathol. 2003;27(11):1448-53.
Velazquez EF, Barreto JE, Rodriguez I, Piris A, Cubilla AL. Limitations in the interpretation of biopsies in patients with penile squamous cell carcinoma. Int J Surg Pathol. 2004;12(2):139-46.
Teichman JM, Sea J, Thompson IM, Elston DM. Noninfectious penile lesions. Am Fam Physician. 2010;81(2):167-74.
Renaud-Vilmer C, Cavelier-Balloy B, Verola O, Morel P, Servant JM, Desgrandchamps F, Dubertret L. Analysis of alterations adjacent to invasive squamous cell carcinoma of the penis and their relationship with associated carcinoma. J Am Acad Dermatol. 2010;62(2):284-90.
Bozzini G, Provenzano M, Romero Otero J, Margreiter M, Garcia Cruz E, Osmolorskij B, Verze P, Pavan N, Sanguedolce F, Buffi N, Ferrucio GG, Taverna G. Role of Penile Doppler US in the Preoperative Assessment of Penile Squamous Cell Carcinoma Patients: Results From a Large Prospective Multicenter European Study. Urology. 2016;90:131-5.
Schlenker B, Tilki D, Seitz M, Bader MJ, Reich O, Schneede P, Hungerhuber E, Stief CG, Gratzke C. Organ-preserving neodymium-yttrium-aluminium-garnet laser therapy for penile carcinoma: a long-term follow-up. BJU Int. 2010;106(6):786-90.
Bandieramonte G, Colecchia M, Mariani L, Lo Vullo S, Pizzocaro G, Piva L, Nicolai N, Salvioni R, Lezzi V, Stefanon B, De Palo G. Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients. Eur Urol. 2008;54(4):875-82.
Musi G, Russo A, Conti A, Mistretta FA, Di Trapani E, Luzzago S, Bianchi R, Renne G, Ramoni S, Ferro M, Matei DV, Cusini M, Carmignani L, de Cobelli O. Thulium-yttrium-aluminium-garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life. World J Urol. 2018;36(2):265-70.
Zreik A, Rewhorn M, Vint R, Khan R, Hendry D. Carbon dioxide laser treatment of penile intraepithelial neoplasia. Surgeon. 2017;15(6):321-24.
Schlenker B, Tilki D, Seitz M, Bader MJ, Reich O, Schneede P, Hungerhuber E, Stief CG, Gratzke C. Organ-preserving neodymium-yttrium-aluminium-garnet laser therapy for penile carcinoma: a long-term follow-up. BJU Int. 2010;106(6):786-90.
Meijer RP, Boon TA, van Venrooij GE, Wijburg CJ. Long-term follow-up after laser therapy for penile carcinoma. Urology. 2007;69(4):759-62.
Windahl T, Andersson SO. Combined laser treatment for penile carcinoma: results after long-term followup. J Urol. 2003;169(6):2118-21.
van Bezooijen BP, Horenblas S, Meinhardt W, Newling DW. Laser therapy for carcinoma in situ of the penis. J Urol. 2001;166(5):1670-1.
Musi G, Russo A, Conti A, Mistretta FA, Di Trapani E, Luzzago S, Bianchi R, Renne G, Ramoni S, Ferro M, Matei DV, Cusini M, Carmignani L, de Cobelli O. Thulium-yttrium-aluminium-garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life. World J Urol. 2018;36(2):265-270.
